论文信息 - Off-Label Promotion, On-Target Sales

Off-Label Promotion, On-Target Sales

Adriane Fugh-Berman and Douglas Melnick describe techniques by which pharmaceutical companies covertly promote off-label drug use even where such promotion is illegal.

A. Fugh-Berman | D. Melnick

[1] T. Hampton. Experts weigh in on promotion, prescription of off-label drugs. , 2007, JAMA.

[2] R. Ward,et al. Off‐label use of medicines: consensus recommendations for evaluating appropriateness , 2006, The Medical journal of Australia.

[3] M. Chren,et al. Narrative Review: The Promotion of Gabapentin: An Analysis of Internal Industry Documents , 2006, Annals of Internal Medicine.

[4] R. Stafford,et al. Off-label prescribing among office-based physicians. , 2006, Archives of internal medicine.

[5] C. Lines,et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. , 2005, The New England journal of medicine.

[6] P. Safar,et al. Misoprostol and the debate over off-label drug use , 2005, Journal of Family Planning and Reproductive Health Care.

[7] R. Stafford,et al. National trends in antiobesity medication use. , 2003, Archives of internal medicine.

[8] P. Darney,et al. Misoprostol and pregnancy. , 2001, The New England journal of medicine.

[9] H. Muir. Dicing with death , 2006 .

[10] H. Muir. Dicing with death : there's a good chance that the pills your doctor prescribed will do you no good and might even harm you. , 2006, New scientist.

[11] Brendan Smoker. A matter of trust. , 2002, Health management technology.

[12] B. Mikulski,et al. Drug Safety : Most Drugs Withdrawn in Recent Years Had Greater Health Risks for Women , 2001 .